Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth
CNBC
—
Pfizer is looking to newer products and acquisitions to offset a declining Covid business.
Pfizer beats Q1 earnings estimates
- Pfizer's newer drugs pushed earnings past Wall Street expectations Quartz —
- Pfizer Posts Better-Than-Expected Revenue, Profit Wall Street Journal —
- Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending Wall Street Journal —
- Earnings Snapshot: Pfizer beats Q1 estimates but misses guidance Seeking Alpha —
- Pfizer in charts: Specialty Care, Oncology and Biosimilars drive Q1 growth, offsetting Primary Care decline Seeking Alpha —